Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

Brian Druker, M.D., Knight Cancer Institute director, JELD-WEN Chair of Leukemia Research; investigator, Howard Hughes Medical Institute. (OHSU/Kristyna Wentz-Graff)

Scott Pierson, M.D., Saint Alphonsus Cancer Institute Medical Director. (Photo courtesy Saint Alphonsus Health System)